SCHEMBL8300510

SCHEMBL8300510

CN1C(=O)c2cccnc2N(S(C)(=O)=O)c2ncccc21

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 1/20 0.42
▸ CES1 P23141 1/20 0.42
▸ BRD4 O60885 15/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ DCLK1 O15075 1/20 0.39
▸ BRDT Q58F21 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790761 0.79 TTR (0.50) TTRCES1BRD4ALDH1A1
SCHEMBL8299917 0.75 TTR (0.40) TTRCES1BRD4ALDH1A1LMNA
SCHEMBL8299587 0.75 CYP3A4 (0.52) BRD4ALDH1A1CASP1SMN1; SMN2
SCHEMBL8299628 0.74 BRD4 (0.45) CES1BRD4ALDH1A1
SCHEMBL8889164 0.74 BRD4 (0.44) TTRCES1BRD4ALDH1A1SMN1; SMN2
SCHEMBL29582820 0.73 DCLK1 (0.48) TTRCES1BRD4ALDH1A1LMNA
SCHEMBL8791033 0.72 BRD4 (0.41) TTRCES1BRD4ALDH1A1LMNA
SCHEMBL9375685 0.71 DRD2 (0.49) TTRCES1BRD4ALDH1A1DCLK1
SCHEMBL8789567 0.71 BRD4 (0.46) TTRCES1BRD4ALDH1A1LMNA
SCHEMBL8790708 0.71 TTR (0.42) TTRCES1BRD4ALDH1A1DCLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 — — EP claimed
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 — — EP disclosed
Send feedback